# Primary squamous cell carcinoma of the breast: a case report

**Authors:** Xibo Liu, Jiahui Chen, Chuanling Hou

PMC · DOI: 10.1007/s12672-024-00958-6 · Discover. Oncology · 2024-04-01

## TL;DR

A rare case of squamous cell carcinoma of the breast with spindle cell features was diagnosed and successfully treated, with the patient remaining disease-free for over four years.

## Contribution

This case report highlights the diagnostic challenges and management of a rare spindle cell variant of breast cancer.

## Key findings

- The tumor exhibited sarcomatoid growth pattern and spindle-shaped cells with severe atypicality.
- Immunohistochemical staining showed positivity for P63, P53, vimentin, and CKpan, but negativity for estrogen receptor and C-erbB-2.
- The patient remained disease-free for over four years following surgery, chemotherapy, and radiotherapy.

## Abstract

Squamous cell carcinoma (SCC) of the breast is a rare variant of invasive breast cancer that has been classified as metaplastic carcinoma. When a tumor is composed of spindle cells, diagnosis is challenging.

A 42-year-old woman with a large mass in the right breast underwent modified radical mastectomy. A pathological examination revealed a tumor with central necrosis in it. The tumor had a sarcomatoid growth pattern and the cells were spindle-shaped with severe atypicality. Immunohistochemical staining showed that P63, P53, vimentin, and CKpan were positive, whereas estrogen receptor and C-erbB-2 were negative. Ki-67 proliferation index was as high as 90%. Therefore, a diagnosis of SCC of the right breast was made. The patient received eight cycles of postoperative chemotherapy with paclitaxel and carboplatin, followed by seven cycles of radiotherapy. During follow-up, the patient also had a left thyroid tumor, and postoperative pathology suggested microinvasive follicular carcinoma. Since breast surgery, the patient has remained disease-free for more than four years.

SCC of the breast with spindle cell and sarcomatoid features is rare. The diagnosis of such tumors requires exclusion of tumors with similar histological morphologies.

## Linked entities

- **Genes:** RPE65 (retinoid isomerohydrolase RPE65) [NCBI Gene 6121], TP53 (tumor protein p53) [NCBI Gene 7157], Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866]
- **Proteins:** PRELID1 (PRELI domain containing 1)
- **Chemicals:** paclitaxel (PubChem CID 36314), carboplatin (PubChem CID 426756)
- **Diseases:** squamous cell carcinoma (MONDO:0005096), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, VIM (vimentin) [NCBI Gene 7431], ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** thyroid tumor (MESH:D013964), Primary squamous cell carcinoma of the breast (MESH:D001943), Squamous cell carcinoma (MESH:D002294), follicular carcinoma (MESH:D018263), necrosis (MESH:D009336), metaplastic carcinoma (MESH:D009369)
- **Chemicals:** paclitaxel (MESH:D017239), carboplatin (MESH:D016190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10984905/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10984905/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC10984905/full.md

---
Source: https://tomesphere.com/paper/PMC10984905